Purchase Order 36C26123P0248
Award Date 11/22/22
Potential Completion Date 9/15/23
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Palo Alto, CA 94304, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Foundation Care LLC, a specialty pharmacy, to provide the drug Iclusig (ponatinib). The contract has a potential value of $110,424.15 and a completion date of September 30, 2022. Foundation Care LLC is a subsidiary of Centene Corporation, a for-profit organization. The contract does not have a set-aside designation. Through this and other federal contract awards,...
- This federal contract award to Foundation Care LLC, a full-service retail and specialty pharmacy, is for the drug Iclusig (ponatinib) for $115,946.48. The contract is a purchase order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21, with a completion date of September 30, 2021. The contract has no set-aside designation. Foundation Care LLC is a subsidiary of the for-profit organization Centene Corporation. Through this and over 60...
- Foundation Care LLC, a specialty pharmacy and subsidiary of Centene Corporation, was awarded a firm fixed-price purchase order by Veterans Integrated Service Network 2 (VISN 2) on February 4, 2026, to supply 60 units of Iclusig 15mg, a specialized chemotherapy medication used to treat blood disorders including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The contract carries a ceiling value of $28,771.50 with an ultimate completion date of May 4,...
- Foundation Care LLC, a for-profit specialty pharmacy and subsidiary of Centene Corporation, has been awarded a $13,956.72 firm-fixed-price purchase order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6. The contract is for the provision of Iclusig 15 mg tablets to the Earth City, Missouri VA medical center, with a period of performance through February 29, 2024. Iclusig is used to treat chronic myeloid leukemia and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $26,250 firm fixed price purchase order to Foundation Medicine, Inc. to provide maintenance services for the Hematologic NGS Hematologic Malignancies Panels at the Richard L. Roudebush VA Medical Center in Indianapolis, Indiana. This order was issued under Foundation Medicine's indefinite delivery contract with the VA Headquarters, valued at over $111 million, to support VA...
- The U.S. Department of Veterans Affairs (VA) awarded a $173,208.96 firm-fixed-price delivery order contract to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide bulk orders of the oncology medication ICLUSIG (ponatinib). The contract was issued against Takeda's existing General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and supports the VA's provision of specialized cancer treatments to veterans nationwide....
- This federal contract award is for the delivery of the specialty medication ICLUSIG 15 MG to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract is a Delivery Order placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. It is a firm-fixed-price contract with a ceiling value of $13,956.72 and an...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to the prime contractor Palisade-Heritage JV LLC, a for-profit, veteran-owned small business. The $22,000 firm fixed price delivery order is for first fill pharmacy services, which includes pharmacy benefit management, medication counseling, and related offerings. The contract is part of the VHA's Veterans Integrated Service Network (VISN) program and is not set aside....
- Takeda Pharmaceuticals America, Inc., a foreign-owned biopharmaceutical manufacturer and subsidiary of Takeda Pharmaceutical Company Limited, was awarded a delivery order on July 31, 2025, for ICLUSIG 15 mg (ponatinib), an oncology medication, with a ceiling value of $14,197.39. This firm fixed-price delivery order was issued without a small business set-aside and is set to be completed by August 5, 2025. The contract will be performed in Earth City, Missouri, and is funded by Veterans...
- This is a delivery order award to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, under the company's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract, valued at $27,913.44, is for the supply of the oncology medication ICLUSIG (ponatinib) to the U.S. Department of Veterans Affairs (VA). The award is part of a larger Blanket Purchase Agreement (BPA) between Takeda and the VA National...